|
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
18 December 2017 Last Updated at 4:48 pm
Natco launches Hepatitis B drug
New Delhi, Dec 18 Natco Pharma today said it has launched a generic version of Tenofovir Alafenamide, a drug used to treat chronic Hepatitis B in the country.
The company is one of the first entities to launch the generic version of the drug under its brand Tafnat, Natco Pharma said in a regulatory filing.
Natco is producing Tafnat under license from Medicines Patent Pool (MPP) and Gilead Sciences.
The company said it has priced the medicine at Rs 1,900 for a monthly pack of 30 tablets for the Indian market.
2017年12月18日最后更新于4:48 pm
Natco推出乙肝药物
新德里，12月18日Natco制药公司今天宣布推出替诺福韦Alafenamide的仿制药，用于治疗慢性乙型肝炎。
该公司是最早在其品牌Tafnat下推出仿制药的实体之一，Natco Pharma在一份监管文件中表示。
Natco正在根据药品专利池（MPP）和Gilead Sciences的许可生产Tafnat。
该公司表示，已经为印度市场每月一包30片的价格定价了1,900卢比的药品。
|
|
发表于 2017-12-18 20:12
